Français
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Page 1 de 41 résultats
Composite for Clostridium difficile diarrhea and pseudomembranous colitis
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to a preventive and curative pharmaceutical composition for Clostridium difficile diarrhea and pseudomembranous colitis.
2. Description of the Prior Art
For the cure of Clostridium difficile diarrhea and pseudomembranous
Treatment of antibiotic associated diarrhea
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
FIELD OF THE INVENTION
This invention relates to treatment of antibiotic associated diarrhea, including Clostridium difficile associated diarrhea (CDAD) and pseudomembranous colitis (PMC). More specifically, the invention concerns neutralization of C. difficile toxin A associated with
Method of treating ulcerative colitis
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
The present invention relates to a method of treating a mammalian creature, preferably a human, having ulcerative colitis or inflammation of the colon.
The term "Inflammatory Bowel Disease" is a designation commonly used for two related, but distinct, chronic inflammatory conditions affecting the
Tannin formulation for treating GI spasms in a subject having Crohn's disease or ulcerative colitis
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
BACKGROUND
1. Field of the Invention
The teachings provided herein relate to methods of treating gastrointestinal spasms.
2. Description of Related Art
Antispasmodics can be used to prevent spasms of the stomach, intestine, uterus, or urinary bladder. Gastrointestinal spasms, for example, can be
Methods of treating gastrointestinal spasms in a subject having Crohn's Disease or ulcerative colitis
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
BACKGROUND
1. Field of the Invention
The teachings provided herein relate to methods of treating gastrointestinal spasms.
2. Description of Related Art
Antispasmodics can be used to prevent spasms of the stomach, intestine, uterus, or urinary bladder. Gastrointestinal spasms, for example, can be
Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
FIELD OF INVENTION
The present invention is directed to modulators of the TGR5 receptor useful in the treatment of TGR5 mediated diseases or disorders. Specifically, the invention is concerned with compounds and compositions thereof, which activate the TGR5 receptor, methods of treating diseases or
Capsules for oral preparations and capsule preparations for oral administration
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
FIELD OF THE INVENTION
1. Background of the Invention
This invention relates to capsules for preparations for oral administration and also to capsule preparations for oral administration using said capsules. More particularly, this invention relates to capsules being able to be administered orally
Fatty acid delivery system comprising a hydrolyzable bond
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
This application claims benefit of international application PCT/GB94/00713, filed Nov. 17, 1994, published as WO95/13801 May 26, 1995.
FIELD OF THE INVENTION
This invention relates to an agent for use in food, dietary, and the like preparations, and to preparations, formulations and dietary
Oral rehydration solution containing indigestible oligosaccharides
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
FIELD OF THE INVENTION
This invention relates to an oral rehydration solution containing indigestible oligosaccharides for the inhibition of disease states associated with Clostridium difficile.
BACKGROUND OF INVENTION
The successful management of acute diarrhea is still a challenge today. Acute
Inhibition of C. difficile infections by indigestible oligosaccharides
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
FIELD OF THE INVENTION
This invention relates to the use of indigestible oligosaccharides in the inhibition of disease states by Clostridium difficile.
BACKGROUND OF INVENTION
Clostridium difficile (C. difficile) is the leading known cause of nosocomial infections. Greenough et al., "Diarrhea in the
Method of binding and removing toxin A
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
FIELD OF THE INVENTION
This invention relates to treatment of antibiotic associated diarrhea, including Clostridium difficile associated diarrhea (CDAD) and pseudomembranous colitis (PMC). More specifically, the invention concerns neutralization of C. difficile toxin A associated with
Treatment of C. difficile toxin B associated conditions
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
FIELD OF THE INVENTION
This invention relates to treatment of antibiotic associated diarrhea, including Clostridium difficile associated diarrhea (CDAD) and pseudomembranous colitis (PMC) and other conditions associated with C. difficile infection. More specifically, the invention concerns
Treatment of C. difficile toxin B associated conditions
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
FIELD OF THE INVENTION
This invention relates to treatment of antibiotic associated diarrhea, including Clostridium difficile associated diarrhea (CDAD) and pseudomembranous colitis (PMC) and other conditions associated with C. difficile infection. More specifically, the invention concerns
Treatment of C. difficile toxin B associated conditions
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
FIELD OF THE INVENTION
This invention relates to treatment of antibiotic associated diarrhea, including Clostridium difficile associated diarrhea (CDAD) and pseudomembranous colitis (PMC) and other conditions associated with C. difficile infection. More specifically, the invention concerns
Treatment of C. difficile toxin B associated conditions
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
FIELD OF THE INVENTION
This invention relates to treatment of antibiotic associated diarrhea, including Clostridium difficile associated diarrhea (CDAD) and pseudomembranous colitis (PMC) and other conditions associated with C. difficile infection. More specifically, the invention concerns
La base de données d'herbes médicinales la plus complète soutenue par la science
- Fonctionne en 55 langues
- Cures à base de plantes soutenues par la science
- Reconnaissance des herbes par image
- Carte GPS interactive - étiquetez les herbes sur place (à venir)
- Lisez les publications scientifiques liées à votre recherche
- Rechercher les herbes médicinales par leurs effets
- Organisez vos intérêts et restez à jour avec les nouvelles recherches, essais cliniques et brevets
Tapez un symptôme ou une maladie et lisez des informations sur les herbes qui pourraient aider, tapez une herbe et voyez les maladies et symptômes contre lesquels elle est utilisée.
* Toutes les informations sont basées sur des recherches scientifiques publiées
